| Patents for C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom (107,979) |
|---|
| 05/22/2008 | WO2008058867A2 Substituted 4-imidazoles |
| 05/22/2008 | WO2008058402A1 Compounds and methods for treating protein folding disorders |
| 05/22/2008 | WO2008058387A1 Renin inhibitors |
| 05/22/2008 | WO2008043087A3 Bicyclic nitrogen-containing heterocyclic compounds for use as stearoyl coa desaturase inhibitors |
| 05/22/2008 | WO2008042282A3 Imidazole-4, 5-dicarboxamide derivatives as jak-2 modulators |
| 05/22/2008 | WO2008011392A3 Proline urea ccr1 antagonists for the treatment of autoimmune diseases or inflammation |
| 05/22/2008 | WO2008000421A3 Thiazolyl urea derivatives as phosphatidylinositol 3-kinase inhibitors |
| 05/22/2008 | WO2007138431A3 Azabicyclic ether histamine-3 antagonists |
| 05/22/2008 | US20080119654 preparing a solution of esomeprazole salt in one or more solvents (methanol, ethanol, acetone, 2-butanone, ethyl acetate, chloroform) and recovering the salt of esomeprazole in the amorphous form from the solution by the removal of the solvent (distillation, evaporation spray drying, and freeze drying) |
| 05/22/2008 | US20080119653 1,5-dibromopentane is reacted with 5-(4-chlorophenyl)-1-(2,4-dichlorophenyl)-4-methyl-1H-pyrazole-3-carbohydrazide in presence of sodum carbonate base in acetonitrile heated at reflex to form of N-piperidino-5-(4-chlorophenyl)-1-(2,4-dichlorophenyl)-4-methylpyrazole-3-carboxamide or its salts |
| 05/22/2008 | US20080119652 A crystalline form X, Y, Z of Gatifloxacindissolving gatifloxacin in methanol, removing insoluble, adding a base ( triethylamine or diisopropylethylamine), maintaining the reaction mixture at an appropriate temperature, cooling, isolating and drying; bactericides |
| 05/22/2008 | US20080119648 Histone deacetylase inhibitors |
| 05/22/2008 | US20080119643 Based on diaminobenzanilides or, more specifically (aminobenzoylamino),(sulfo-),(methoxy)anilines; stable aqueous solutions;nonbleeding/colorfastness; excellent degrees of exhaustion with high color strength; dyeing natural or synthetic materials, particularly, paper; neutral or greenish-yellow hues |
| 05/22/2008 | US20080119535 Aminomethyl-4-imidazoles |
| 05/22/2008 | US20080119526 Ep2 receptor agonists |
| 05/22/2008 | US20080119524 Treating conditions related to Ras or Ras-like protein prenylation such as cancer, restenosis, psoriasis, endometriosis, atherosclerosis, ischemia, myocardial ischemic disorders; amide-functional pyrazole compounds containing 2,2-dimethylcyclobutan-1,3-ylene moiety |
| 05/22/2008 | US20080119523 3-[(2-{[4-(hexyloxycarbonylaminoiminomethyl) phenylamino]methyl}-1-methyl-1h-benzimidazol-5- carbonyl)pyridin-2-ylamino]propionic acid ethylester methansulfonate and its use as a medicament |
| 05/22/2008 | US20080119522 5,6-dichloro-2-(2,2,2-trifluoro-ethyl)-1H-benzimidazole for example; use for prostate cancer, benign prostatic hyperplasia (BPH), hirsutism, alopecia, anorexia nervosa, breast cancer, acne, AIDS, cachexia, as a male contraceptive, and/or as a male performance enhancer |
| 05/22/2008 | US20080119521 Butyrlcholinesterase Selective Inhibitors |
| 05/22/2008 | US20080119520 Disorders related to memory and cognition processes, neurological processes, cardiovascular function, and body weight; benzoxazole, benzimidazole, and indole compounds substituted with pyrrole, azepane, piperidine or azetidine e.g. 4-{2-[2-(2-methyl-pyrrolidin-1-yl)-ethyl]-benzooxazol-5-yl}-benzonitrile |
| 05/22/2008 | US20080119516 2-'4(Phenylamino)-Piperidin-1-Yl!-N-Phenyl-Acetamine Derivatives and Related Compounds as Neuropeptide Y5 (NPY5) Ligands for the Treatment of Obesity |
| 05/22/2008 | US20080119490 Viral Polymerase Inhibitors |
| 05/22/2008 | US20080119489 Imidazole derivatives |
| 05/22/2008 | US20080119488 Modulators Of Nuclear Receptors |
| 05/22/2008 | US20080119487 Novel non-imidazole compounds |
| 05/22/2008 | US20080119481 CNS disorders; sexual disorders; 5-HT1A binding agent |
| 05/22/2008 | US20080119476 Cetp Inhibitors |
| 05/22/2008 | US20080119474 5,6-bis(4-methoxyphenyl)-2-ethyl-2H-pyridazin-3-one; interleukin-1 beta antagonist; collagenase inhibitor; analgesic, antiinflammatory, antiarthritic, antiischemic agents; autoimmune disease, rheumatic diseases; osteoporosis |
| 05/22/2008 | US20080119470 8-hydroxy-3H-quinazolin-4-(thi)one derivatives; ability to enter CNS, sequester transition metals Cu, Zn and Fe from various amiloid beta entities, reducing their toxicity; neurodegenerative disorders; Alzheimer's, Parkinson's, Cruetzfeldt-Jacob diseases, amyotrophic lateral sclerosis, cataract |
| 05/22/2008 | US20080119464 N-(4-piperidin-1-yl-phenyl)-2-[5-(thiaxolidine-3-carbonyl)-pyrrolidin-3-ylidene]-acetamide;antidiabetic agents; hyperglycemia, syndrome X, hyperinsulinemia, obesity, atherosclerosis |
| 05/22/2008 | US20080119461 N-(4,6-dimethyl-2-pyridinyl)-L-valyl-(4R) N-((1R,2S)-1-((cyclopropylsulfonyl)carbamoyl)-2-vinylcyclopropyl)-4-((6-methoxy-1-isoquinolinyl)oxy)-L-prolinamide; viricide; synergistic with other active ingredients |
| 05/22/2008 | US20080119453 Bicyclic derivatives as modulators of ion channels |
| 05/22/2008 | US20080119451 N-(2-aminophenyl)-4-(3-methylpyridin-2-yl)benzamide; histone deacetylase (HDAC) and angiogenesis inhibitor; antiproliferative agent; solid tumor cancers, lymphomas, myelomas, melanomas; antiinflammatory agent; arthritis, psoriasis, multiple sclerosis, asthma |
| 05/22/2008 | US20080116453 Transition metal complex and light-emitting device |
| 05/22/2008 | CA2669917A1 Aminopyrrolidines as chemokine receptor antagonists |
| 05/22/2008 | CA2669820A1 Derivatives of 18-amino substituted analogs of the geldamycin hydroquinon with cytotoxic activity for the treatment of cancer |
| 05/22/2008 | CA2669704A1 Sulfoximines as kinase inhibitors |
| 05/22/2008 | CA2669635A1 Piperidine derivative or salt thereof |
| 05/22/2008 | CA2669607A1 Novel 1,2-dihydroquinoline derivative having (substituted phenyl or substituted heterocyclic) carbonyloxy lower alkyl group and ester-introduced phenyl group as substituents |
| 05/22/2008 | CA2669396A1 New polymorphs of ethyl 3-[(2-{[4-(hexyloxycarbonylamino-imino-methyl)-phenylamino]-methyl}-1-methyl-1h-benzimidazole-5-carbonyl)-pyridin-2-yl-amino]-propionate |
| 05/22/2008 | CA2669310A1 Hepatitis c virus inhibitors |
| 05/22/2008 | CA2669221A1 Heterocyclic derivatives as cetp inhibitors |
| 05/22/2008 | CA2669112A1 Substituted 4-imidazoles |
| 05/22/2008 | CA2669080A1 Cannabinoid receptor modulators |
| 05/22/2008 | CA2668744A1 Compounds and methods for treating protein folding disorders |
| 05/22/2008 | CA2668742A1 Renin inhibitors |
| 05/22/2008 | CA2668634A1 Organic compounds |
| 05/22/2008 | CA2668596A1 Novel 1,2-dihydroquinoline derivative having substituted phenylamino lower alkyl group and ester-introduced phenyl group as substituents |
| 05/22/2008 | CA2668592A1 Novel 1,2-dihydroquinoline derivative having substituted phenylchalcogeno lower alkyl group and ester-introduced phenyl group as substituents |
| 05/22/2008 | CA2661338A1 Macrocyclic inhibitors of hepatitis c virus |
| 05/21/2008 | EP1923391A1 Substituted heterocyclic compounds, method for preparing same and pharmaceutical compositions containing them. |
| 05/21/2008 | EP1923390A1 Trisubstituted aryl and heteroaryl derivatives as modulators of metabolism and the prophylaxis and treatment of disorders related thereto |
| 05/21/2008 | EP1923387A1 Acylguanidine derivative or salt thereof |
| 05/21/2008 | EP1922314A1 Delta and epsilon crystal forms of imatinib mesylate |
| 05/21/2008 | EP1922313A1 Pyrazine derivatives useful as adenosine receptor antagonists |
| 05/21/2008 | EP1922309A1 N-phenyl-2-pyrimidine-amine derivatives and process for the preparation thereof |
| 05/21/2008 | EP1922135A1 Hindered cyclic polyamines and their salts for acid gas scrubbing process |
| 05/21/2008 | EP1922068A2 Inhibitors of voltage-gated sodium channels |
| 05/21/2008 | EP1737838B1 Substituted 4-alkyl- and 4-alkanoyl-piperidine derivatives and their use as neurokinin antagonists |
| 05/21/2008 | EP1562595B1 Diaryl ethers as opioid receptor antagonists |
| 05/21/2008 | EP1482924B1 Cathepsin cysteine protease inhibitors |
| 05/21/2008 | EP1434773B1 Heteroaryl substituted tetrazole modulators of metabotropic glutamate receptor-5 |
| 05/21/2008 | EP1362027B1 Acylated 6,7,8,9-tetrahydro-5h-benzocycloheptenyl amines and their use as pharmaceutical |
| 05/21/2008 | EP1284734B1 Isoquinoline derivatives as protein kinase inhibitors |
| 05/21/2008 | EP1261586B1 Cyclopropyl-fused pyrrolidine-based inhibitors of dipeptidyl peptidase iv, processes for their preparation, and their use |
| 05/21/2008 | DE102006054005A1 Neue Polymorphe von New polymorphs of 3-[(2-{[4-(Hexyloxycarbonylamino-imino-methyl)-phenylamino]-methyl}-1-methyl-1H-benzimidazol-5-carbonyl)-pyridin-2-yl-amino]-propionsäure-ethylester |
| 05/21/2008 | CN101184749A Spirocyclic heterocyclic derivatives and methods of their use |
| 05/21/2008 | CN101184748A Process for the syntesis of 5-(methyl-1h-imidazol-1-yl)-3-(tri fluorome th yl)-benzeneamine |
| 05/21/2008 | CN101184747A Cyano anthranilamide insecticides |
| 05/21/2008 | CN101184733A Novel piperidine carboxylic acid amide derivatives |
| 05/21/2008 | CN101184731A New sulfonylindoline compounds |
| 05/21/2008 | CN101184728A Peptide deformylase (PDF) inhibitors 4 |
| 05/21/2008 | CN101184490A Piperazinyl substituted cyclohexane-1,4-diamines |
| 05/21/2008 | CN101184393A Bicyclic 5-hydroxypyrazolines, method for producing the same and agents comprising the same |
| 05/21/2008 | CN100389113C Nitrogenous heterocyclic compound and medicine containing the same |
| 05/21/2008 | CN100389110C Process of preparing aromatic ring substituted ixooxazoline compound |
| 05/21/2008 | CN100389109C Non-nucleoside reverse transcriptase inhibitors |
| 05/21/2008 | CN100388918C Pharmaceutical compositions based on azetidine derivatives |
| 05/20/2008 | US7375232 Ortho-heterocyclic substituted aryl amides for controlling invertebrate pests |
| 05/20/2008 | US7375228 Antiinflammatory agents; inflammatory bowel disorders; capable of complexing with a deacetylase catalytic site and/or a metal ion |
| 05/20/2008 | US7375227 May be combined with ACE inhibitors, angiotensin or endothelin receptor antagonists, vasopressin antagonists, alpha- and beta-adrenergic antagonists, TNFalpha antagonists, and peroxisome proliferator activator receptor modulators; cardiovascular, renal, metabolic, pulmonary and psychological disorders |
| 05/20/2008 | US7375222 anti-dementia agent which uses a BEC 1 potassium channel inhibitor as the active ingredient; to improve learning disorder |
| 05/20/2008 | US7375134 N1-(1-cyanocyclopropyl)-4-fluoro-N2-{(1S)-2,2,2-trifluoro-1-[4'-(methylsulfonyl)-1,1'-biphenyl-4-yl]ethyl}-L-leucinamide; osteoporosis and other bone loss disorders |
| 05/20/2008 | US7375125 Dietetics, cognition activators, cardiovascular disorders, analgesics, immunomoderators |
| 05/20/2008 | US7375122 new insecticides and acaricides, and particularly for compounds that have new or atypical modes of action |
| 05/20/2008 | US7375118 Phenyl-indole compounds for modulating IgE and Inhibiting cellular proliferation |
| 05/20/2008 | US7375116 NMDA (N-methyl-D-aspartate) receptors; eg 6-(4-benzylpiperidin-1-carbonyl)-1,5-dihydro-oxazolo[4,5-f]indole-2-one |
| 05/20/2008 | US7375115 Gastrointestinal disorders; antiemetic agents; irritable bowel disorders; antipruritic agents |
| 05/20/2008 | US7375114 minimal side effects, selectivity, potency, pharmacokinetics, duration of action; CNS disorders like cognitive, behavioral, mood, autonomic functions; 1-isopropyl-2-oxo-1,2-dihydro-quinoline-3-carboxylic acid {(1S,3R,5R)-8-[3-acetylamino-2-hydroxypropyl]-8-azabicyclo[3.2.1]oct-3-yl}amide |
| 05/20/2008 | US7375110 Nicotinic cholinergic receptors modulators; pain, neurodegenerative diseases; neurotransmission dysfuctions; central and autonomic nervous systems disorders; 1'-(3-pyridyl)-spiro[1-azabicyclo[2.2.1]heptane-2,3'-pyrrolidine] |
| 05/20/2008 | US7375102 inflammatory diseases, immune disorders, multiple sclerosis, rheumatoid arthritis, psoriasis; CXCR3 chemokine receptor modulators; 2-(4-fluoro-3-trifluoromethyl-phenyl)-N-(2-methanesulfonyl-ethyl)-N-(1-{4-oxo-3-[4-(2,2,2-trifluoro-ethoxy)-phenyl]-3,4-dihydro-pyrido[2,3-d]pyrimidin-2-yl}-ethyl)-acetamide |
| 05/20/2008 | US7375101 N-(7-chloro-2,3-dihydro-1-methyl-2-oxo-5-phenyl-1H-1,4-benzodiazepin-3-yl)-N'-(5isoquinolinyl)-thiourea; bradykinin receptor B2 antagonists;analgesic; septic shock, pancreatitis, edema, rhinitis, asthma, colitis, arthritis, hepatorenal syndrome, cancer, bacterial and viral infections, ulcerative colitis |
| 05/20/2008 | US7375099 Malonamide derivatives |
| 05/20/2008 | CA2432223C Pyrazole compounds useful as protein kinase inhibitors |
| 05/20/2008 | CA2415681C Pyrrolidine derivatives |
| 05/20/2008 | CA2395717C Fused imidazolium derivatives |
| 05/20/2008 | CA2350801C Hiv replication inhibiting pyrimidines |
| 05/20/2008 | CA2344308C Taurolidine and/or taurultam against infectious ulcer or gastritis |
| 05/20/2008 | CA2322309C Quinolin-4-yl derivatives |
| 05/20/2008 | CA2298461C Heterocyclic substituted 4-benzoyl-pyrazole as herbicides |